Meeting face-to-face with this vital group to share knowledge and collaborate is an example of Commonwealth Medicine’s commitment to supporting Medicaid Pharmacy teams in their service to members.
Does your health care organization have clearly defined goals and metrics? Do teams and employees feel connected to these goals? Do they understand the impact they have on the metrics? If you answered "no" to any of these questions, you may have an opportunity to enhance your organization's strategic planning.
Cell and gene-based therapies (CGTs) have captured our imagination for their potential to cure disease after a single course of therapy but have also raised eyebrows for their astronomical price tags.
A new Centers for Medicare & Medicaid Services (CMS) rule, effective July 1, 2022, will offer Medicaid patients access to needed therapies while providing options to engage in payment arrangements – value-based purchasing (VBP) – that allow flexibility for states, including the potential to o
What percentage of your health care organization’s employees is directly contributing to projects or initiatives aligned with company strategy?
For decades, Massachusetts has been an innovative leader in developing behavioral health programs and policies and implemented various statewide provider consultation programs aimed at addressing specific behavioral health (BH) conditions.
The generosity of the nearly 720,000 social workers in America is being recognized this month with the theme "The Time is Right for Social Work." The theme underscores the positive contributions so
“Sticks and stones may break my bones, but words will never hurt me.”
Diversity is not just nice to have in business – it is imperative to drive innovation, deliver relevant products and services that resonate with customers, and enhance corporate culture and productivity.
Millions of people suffer from debilitating and potentially deadly health conditions, with limited (if any) treatment options available to them. The Accelerated Approval Pathway (AAP) offers patients access to promising, yet unproven, treatments in a timely manner. The question remains: Is it fulfilling its potential?
